Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Terry Mcguire - aVenture Research

Terry Mcguire

AddedFeb 13, 2024

UpdatedOct 11, 2026

Terry Mcguire

Terry Mcguire

Co-Founder, Polaris Partners

Terry Mcguire's Career

Polaris Partners

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Investment FirmBoston, MA, US

Co-Founder

Lyra Therapeutics

Public$264.1MWatertown, MA, US

Board Member· Board

Seer

Public$169.5MRedwood City, CA, US

Board Member· Board

Alector

Public$269.5MSan Francisco, CA, US

Board Member· Board

WikiCell Designs

Series A$10MCambridge, MA, US

Board Member· Board

Adimab

Public$45.5MLebanon, NH, US

Board Member· Board

Vets First Choice

$293.5MPortland, ME, US

Board Member· Board

Tectonic Therapeutic

$80MWatertown, MA, US

Board Member· Board

Iora Health

$349.3MBoston, MA, US

Board Member· Board

People Similar to Terry Mcguire

Fran HellerFounder & CEO · Good2Go

Mike RossBoard Member · Deciphera Pharmaceuticals

onehubchennaiBoard Member · Adaptive Biotechnologies

Leadership at Polaris Partners

Jon FlintCo-Founder

Steve ArnoldCo-Founder

Similar to Polaris Partners

Polaris Growth FundBoston, MA, USest. 2018Polaris Growth FundBoston, MA, US · est. 2018

PGF, a software-focused investment fund, collaboratively partners with founder-owned tech firms, driving profitable growth and expansion.

Investment Firm17

Polaris Founders CapitalBoston, MA, USest. 1997Polaris Founders CapitalBoston, MA, US · est. 1997

Minority-led Polaris Founders Capital invests significantly in rapid-growth companies.

Investment Firm6

Polaris CapitalNew York City, NY, USest. 2010Polaris CapitalNew York City, NY, US · est. 2010

Polaris Capital: A diversified private investment firm, focusing on multiple sectors since 2010.

Investment Firm7

Polaris Venture CapitalTel Aviv, Tel Aviv District, ILPolaris Venture CapitalTel Aviv, Tel Aviv District, IL

Polaris Venture Capital, an Israel-based financial firm, manages $700M+ in equity investments, specializing in tech partnerships.

Investment Firm50

Leadership at Lyra Therapeutics

Konstantin PoukalovBoard Member

Nancy SnydermanBoard Member

Paulina HillBoard Member

Maria BerkmanBoard Member

Dennis J DoughertyBoard Member

Maria PalasisCEO

Similar to Lyra Therapeutics

Lyric PharmaceuticalsSan Francisco, CA, USTherapeuticsest. 2013Lyric PharmaceuticalsSan Francisco, CA, US · est. 2013

Lyric, a clinical-stage company, innovates gastrointestinal therapeutics for unmet hospital needs.

Series A · $20.4M6

Leadership at Seer

Omid FarokhzadChief Executive Officer

David HallalBoard Member

Bob LangerBoard Member

Rachel HaurwitzBoard Member

Philip MaCo-Founder

John BirbeckBoard Member

Similar to Seer

Quantum-SiGuilford, CT, USProtein Sequencingest. 2013Quantum-SiGuilford, CT, US · est. 2013

Quantum-Si: A unique space empowering bright minds to solve tough problems and pioneer new science.

Public · $425M196

Leadership at Alector

Arnon RosenthalBoard Member

Richard SchellerBoard Member

Dave WehnerBoard Member

Louis J. Lavigne Jr.Board Member

Similar to Alector

Denali TherapeuticsSan Francisco, CA, USBiotechest. 2015Denali TherapeuticsSan Francisco, CA, US · est. 2015

Denali Therapeutics, a US-based biotech firm, develops medicines for neurodegenerative diseases.

Public · $622M427

Leadership at WikiCell Designs

Robert ConnellyFounder

Noubar AfeyanBoard Member

Similar to WikiCell Designs

DisSolvesPittsburgh, PA, USPackagingest. 2000DisSolvesPittsburgh, PA, US · est. 2000

DisSolves provides convenient, dissolvable drink mix packaging using natural, plant-based ingredients for everyday ease.

UuvipakBrisbane, Queensland, AUMaterials, Packagingest. 2021UuvipakBrisbane, Queensland, AU · est. 2021

Uuvipak: Turning food and beverage byproducts into 100% compostable and edible items.

Pre-Seed · $100k2

BooxPetaluma, CA, USPackagingest. 2019BooxPetaluma, CA, US · est. 2019

Boox: An eco-conscious packaging company mitigating environmental harm from online consumerism.

Series A · $22M5

TemperPack TechnologiesRichmond, VA, USPackagingest. 2015TemperPack TechnologiesRichmond, VA, US · est. 2015

TemperPack Technologies: Eco-friendly cold-chain packaging for meal kits, life sciences, and biologic drugs.

Late Stage Private · $208.9M259

Recent news

Adimab Collaborator GSK Receives Additional Marketing Approval for DepemokimabPRNewswire · 2026

Adimab Records Another Year of Double-Digit Clinical Program GrowthPRNewswire · 2026

Adimab Reports Strong Partnering Year for 2025PRNewswire · 2026

Leadership at Adimab

K. Dane WittrupChairman of Scientific Advisory Board

Bill MarisBoard Member

Tillman GerngrossBoard Member

Similar to Adimab

OmniAbEmeryville, CA, USAntibody Discoveryest. 2021OmniAbEmeryville, CA, US · est. 2021

OmniAb: Your pharmaceutical partner in discovering next-generation therapeutics through diverse antibody repertoires.

Public · $70M175

Leadership at Vets First Choice

Ed CahillBoard Member

Betsy AtkinsBoard Member

Ravi SachdevBoard Member

Sarah KimBoard Member

Ben ShawFounder

Similar to Vets First Choice

VetsourcePortland, OR, USPet Medicationsest. 2008VetsourcePortland, OR, US · est. 2008

VetSource, established in 2008, is a trusted, fully-licensed pharmacy partner for veterinarians, offering safe, secure home delivery of pet medications.

Series D · $60M750

Leadership at Tectonic Therapeutic

Alise ReicinCEO

Andrew KruseCo-Founder

Timothy SpringerCo-Founder

Praveen TipirneniBoard Member

Similar to Tectonic Therapeutic

Tavotek BiotherapeuticsGwynedd, PA, USBiopharmaceuticals, Therapeuticsest. 2019Tavotek BiotherapeuticsGwynedd, PA, US · est. 2019

Tavotek: A biopharmaceutical company innovating therapies for oncology and autoimmune diseases.

Series B · $55M24

Leadership at Iora Health

Liam DonohueBoard Member

Christopher J. McKownBoard Member

Rushika FernandopulleCo-Founder

Similar to Iora Health

One MedicalSan Francisco, CA, USPrimary Care, Telemedicineest. 2007One MedicalSan Francisco, CA, US · est. 2007

One Medical, a US-based healthcare company, offers tech-powered, membership-based primary care services both in-office and virtually.

Privia HealthArlington, VA, USHealthcare, Softwareest. 2007Privia HealthArlington, VA, US · est. 2007

Privia Health: A Virginia-based medical organization offering web-enabled health and care management services across the US.

Public · $417.5M964

Oak Street HealthChicago, IL, USPrimary Careest. 2012Oak Street HealthChicago, IL, US · est. 2012

Oak Street Health operates value-based primary care centers for Medicare adults as a CVS Health company.

VillageMDChicago, IL, USHealthcare, Physician Supportest. 2013VillageMDChicago, IL, US · est. 2013

VillageMD: Enhancing healthcare with advanced tools, technology, and support for physicians.

LyndraWatertown, MA, USPharmaceuticals, Therapiesest. 2015

LyndraWatertown, MA, US · est. 2015

US-based Lyndra Therapeutics develops therapies for Alzheimer's, HIV, opioid use disorder, and schizophrenia.

Series E · $284.6M161

Cara TherapeuticsStamford, CT, USDrugs, Therapeuticsest. 2004Cara TherapeuticsStamford, CT, US · est. 2004

Cara Therapeutics, a Connecticut-based medical firm, develops novel drugs for pain and inflammation treatment.

Public · $517.2M106

Cyrano TherapeuticsDelray Beach, FL, USPharmaceuticals, Therapeuticsest. 2014Cyrano TherapeuticsDelray Beach, FL, US · est. 2014

Cyrano Therapeutics: Innovating intranasal solutions to restore taste and smell functions.

Series B · $21.8M7

Glyphic BiotechnologiesNew York City, NY, USProtein Sequencingest. 2021

Glyphic BiotechnologiesNew York City, NY, US · est. 2021

Glyphic: A global consulting firm providing innovative business solutions with Fortune 1000 companies using top tech platforms.

Angel · $10.6M25

Applied ProteomicsSan Diego, CA, USDiagnostic Testsest. 2006Applied ProteomicsSan Diego, CA, US · est. 2006

Applied Proteomics: Advancing proteomics with our protein biomarker discovery platform.

Series C · $54.5M32

EncodiaSan Diego, CA, USProtein Analysisest. 2015EncodiaSan Diego, CA, US · est. 2015

Encodia, a private biotech firm, revolutionizes proteomics with scalable protein analysis via ProteoCode technology.

Series C · $75M69

SelonterraSan Mateo, CA, USDiagnostics, Therapeuticsest. 2017

SelonterraSan Mateo, CA, US · est. 2017

Selonterra: A venture-backed biopharmaceutical firm in SF, specializing in Alzheimer's and Parkinson's therapies.

$2.5M8

Link MedicineCambridge, MA, USMedical Productsest. 2005Link MedicineCambridge, MA, US · est. 2005

Link Medicine Corp: A US-based provider of innovative therapies and medical products for neurodegenerative diseases.

Public · $64.8M30

NeuralyGermantown, MD, USTherapeuticsest. 2016NeuralyGermantown, MD, US · est. 2016

Neuraly, Inc.: A biotech firm developing neuro-protective therapies for neurological disorders.

Series A · $36M125

Board Member

Philip ChaseBoard Member

Errik AndersonBoard Member

Alloy TherapeuticsWaltham, MA, USAntibody Discovery, Biotech Platformsest. 2017

Alloy TherapeuticsWaltham, MA, US · est. 2017

Alloy Therapeutics: Democratizing drug discovery with innovative biotech platforms since 2017.

Series E · $168.3M134

InfinimmuneAlameda, CA, USAntibody Drugsest. 2022InfinimmuneAlameda, CA, US · est. 2022

Infinimmune is an Alameda, California biotechnology company discovering antibody therapeutics from sequenced human immune repertoires.

Series A · $87M7

ProteineaNewton, MA, USAntibody Medicinesest. 2020ProteineaNewton, MA, US · est. 2020

Proteinea: An Egypt/US-based biotech startup revolutionizing bio-manufacturing with insect-based platforms.

Seed · $2.8M58

First Choice Pet CareTrophy Club, TX, USManagement, Vet Careest. 2014

First Choice Pet CareTrophy Club, TX, US · est. 2014

Austin-based First Choice Pet Care Inc. offers vet care management services since 2014.

Angel · $4.6M75

VetcoveMiami, FL, USVeterinary Suppliesest. 2015VetcoveMiami, FL, US · est. 2015

Vetcove: Streamlining vet supply purchases for healthier pets nationwide.

OttoAustin, TX, USVeterinary Softwareest. 2015OttoAustin, TX, US · est. 2015

Otto, your tech partner for modern veterinary care, automating tedious tasks for efficiency.

Series B · $50M88

Aro BiotherapeuticsPhiladelphia, PA, USGenetic Medicinesest. 2018

Aro BiotherapeuticsPhiladelphia, PA, US · est. 2018

Aro Biotherapeutics: Pioneering tissue-targeted genetic medicines via proprietary Centyrin technology.

Series B · $166.5M48

TheradaptiveFrederick, MD, USTherapeuticsest. 2016TheradaptiveFrederick, MD, US · est. 2016

Theradaptive, Inc.: A global pharmaceutical firm developing targeted tissue repair therapeutics via THX1 platform.

Series A · $33.4M23

Aardvark TherapeuticsSan Diego, CA, USTherapeuticsest. 2017Aardvark TherapeuticsSan Diego, CA, US · est. 2017

Aardvark Therapeutics: Developing novel therapeutics for metabolic diseases and inflammation.

Public · $44M38